Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Domestic airline fuel surcharges to increase again starting May 16

Domestic airline fuel surcharges to increase again starting May 16

金十金十2026/05/12 08:55
Show original
Golden Ten Data reported on May 12 that some airline ticket agents have received notifications from airlines that domestic flight fuel surcharges are planned to be increased starting May 16. For routes of 800 kilometers (inclusive) or less, the surcharge will be 90 yuan; for routes above 800 kilometers, 170 yuan. Currently, the fuel surcharge is 60 yuan for routes of 800 kilometers (inclusive) or less, and 120 yuan for routes above 800 kilometers, which means that domestic flight fuel surcharges will be raised by 30 yuan and 50 yuan respectively in May. Last month, the domestic flight fuel surcharge increased fivefold. Typically, fuel surcharges are adjusted on the 5th of each month, but this month’s adjustment has been postponed to the 16th.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11